Simple blood test may predict COVID-19 danger in transplant patients
NCT ID NCT04369456
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a blood sample can predict how severe COVID-19 will become in kidney transplant patients with mild to moderate symptoms. Researchers measured a protein called IL-6 after stimulating the blood sample. They followed 52 patients to see if IL-6 levels were linked to worsening illness, such as needing intensive care. The goal is to find early warning signs to improve patient care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors identify which kidney transplant patients with COVID-19 are at higher risk of severe illness, allowing earlier intervention.
What could go wrong
This is a small, observational study (52 participants) that only looks at biomarkers, not a treatment. The findings may not apply to all patients or lead to direct clinical changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONAVIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHM
Marseille, 13000, France
-
APHP
Paris, 75000, France
-
Lyon Univerity Hospital
Lyon, 69000, France
-
Montpellier University Hospital
Montpellier, 34000, France
-
Saint Etienne University Hospital
Saint-Etienne, 42000, France
-
Strasbourg Univeristy Hospital
Strasbourg, 67000, France
-
University Nice Hospital
Nice, 06000, France